Abraxane Combined With Xeloda as Neo-Adjuvant Chemotherapy in Early Breast Cancer

NCT03647514 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Abraxane
DRUG: Xeloda

Sponsor

Zhejiang Cancer Hospital